Crossmark

Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines reveals that onametostat reduces proliferation and viability in both normoxic and hypoxic conditions

Crossref DOI link: https://doi.org/10.1038/s41598-024-54707-4

Published Online: 2024-02-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lavogina, Darja

Krõlov, Mattias Kaspar

Vellama, Hans

Modhukur, Vijayachitra

Di Nisio, Valentina

Lust, Helen

Eskla, Kattri-Liis

Salumets, Andres

Jaal, Jana
Funding

Funding for this research was provided by:

Estonian Ministry of Education and Research and the Estonian Research Council (PRG454)

Estonian Ministry of Education and Research and the Estonian Research Council (PUT1077)

Estonian Ministry of Education and Research and the Estonian Research Council (PRG1076)

European Regional Development Fund (2014–2020.4.01.15-0012)

Horizon 2020 innovation grant (ERIN, grant no. EU952516)

Institute of Clinical Medicine, University of Tartu, Estonia (PMVCMHO)
License Information

Text and Data Mining valid from 2024-02-21

Version of Record valid from 2024-02-21
More Information

Article History

Received: 25 July 2023

Accepted: 15 February 2024

First Online: 21 February 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below